Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Cassiopea SpA    SKIN   IT0005108359

CASSIOPEA SPA (SKIN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
09/18/2018 09/19/2018 09/20/2018 09/21/2018 09/24/2018 Date
57.6(c) 55.4(c) 58.2(c) 56.8(c) 57 Last
2 770 2 518 3 758 3 779 647 Volume
+0.70% -3.82% +5.05% -2.41% +0.35% Change
More quotes
Financials (EUR)
Sales 2018 -
EBIT 2018 -12,6 M
Net income 2018 -11,9 M
Finance 2018 30,3 M
Yield 2018 -
Sales 2019 -
EBIT 2019 -48,2 M
Net income 2019 -53,4 M
Finance 2019 54,4 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 0
EV / Sales2019 0
Capitalization 504 M
More Financials
Company
Cassiopea SpA is a clinical-stage specialty pharmaceutical company.It engages in developing and commercializing and medical dermatology products focusing on the topical treatment of acne, androgenic alopecia, and genital warts.The company products include Winlevi, Breezula, CB-06-02 and... 
Sector
Pharmaceuticals
Calendar
02/21Earnings Release
More about the company
Latest news on CASSIOPEA SPA
07/31CASSIOPEA : Command and control system
AQ
07/19Cassiopea Announces Top Line Positive Proof of Concept Phase II Results for C..
TE
07/19CASSIOPEA : Announces Top Line Positive Proof of Concept Phase II Results for CB..
AQ
07/18Cassiopea Announces Results for First Half of 2018
TE
07/18CASSIOPEA : Announces Results for First Half of 2018
AQ
07/16Cassiopea Announces Very Positive Interim Analysis Phase 2 Results for Breezu..
TE
07/16CASSIOPEA : Announces Very Positive Interim Analysis Phase 2 Results for Breezul..
AQ
07/13CASSIOPEA SPA : half-yearly earnings release
07/10Cassiopea Announces Very Positive Top-Line Phase 3 Results for Winlevi® (Clas..
TE
07/10CASSIOPEA : Announces Very Positive Top-Line Phase 3 Results for Winlevi® (Clasc..
AQ
More news
Sector news : Specialty & Advanced Pharmaceuticals
08:30aASTRAZENECA : Mixed Results from Farxiga Trial
DJ
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
03:05aAs China builds biotech sector, cash floods U.S. startups
RE
09/23ASTRAZENECA CEO WARNS OF MEDICINE SH : Sunday Times
RE
09/22J&J UNIT : Esketamine Study Didn't Show Statistical Significance for Primary End..
DJ
More sector news : Specialty & Advanced Pharmaceuticals
Latest Tweets
09/20??bios today:? ??? $PHARM.ing +19% ??Expedeon $EXN +13.5% Mologen $MGNK +6.5.. 
08/27??bios today: slightly ?, ??closed, weak TOs ???Neovacs $ALNEV +5.5% $NANO.b..
1
02/21#ANSA | TIM offices searched on Cassiopea projec (3) - Anti-trust weighing po.. 
2017Cassiopea announces completion of recruitment of Phase II dose ranging trial .. 
2017Wake up! The team pulsed water at the Cassiopea jellyfish to disturb their 's..
1
More tweets
Qtime:8
Chart CASSIOPEA SPA
Duration : Period :
Cassiopea SpA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CASSIOPEA SPA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 59,2 €
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Diana Harbort Chief Executive Officer & Executive Director
Jan Egbert de Vries Non-Executive Chairman
Marco Pasero Chief Operating Officer
Hans Christoph Tanner CFO, Head-Investor & Media Relations
Luigi Moro Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
CASSIOPEA SPA63.22%606
ABBVIE-4.60%140 343
MERCK KGAA-2.89%13 233
KYOWA HAKKO KIRIN CO LTD-6.21%10 668
JAZZ PHARMACEUTICALS PLC21.63%9 929
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD53.61%8 308